Folic Acid Supplementation in Dementia: A Preliminary Report

Abstract

Recent work on high plasma homocysteine levels in patients at risk for developing Alzheimer's disease has led to the hypothesis that folic acid supplementation might reduce risk in such patients. The authors report on the effects of folic acid 10 mg/day versus placebo on 11 patients (only 7 completers) with dementia and low-normal folic acid levels. This is the first study evaluating folic acid or placebo in patients with dementia. Subjects had low-normal baseline folic acid levels. The magnitude of change between baseline and second testing was not statistically significant between the 2 groups. However, there was a trend for the folate group to perform worse on two specific cognitive measures, suggesting a possible trend toward worsening of some cognitive abilities after the folic acid. The folic acid in very high doses was well tolerated. Larger studies are necessary before empirically administering folic acid to patients already suffering from dementia. (J Geriatr Psychiatry Neurol 2003; 16:156-159).

Get full access to this article

View all access options for this article.

References

1. Sommer, BR, Wolkowitz OM. RBC folic acid levels and cognitive performance in elderly patients: a preliminary report. Biol Psychiatry 1988; 24:352-354.

2. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 2002; 346:476-483.

3. Clark R, Smith D, Jobst KA, et al. Folate, vitamin B12 and serum total homocysteine levels in confirmed Alzheimer's disease. Arch Neurol 1998; 55:1449-1455.

4. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993; 270:2693-2698.

5. Yukawa M, Naka H, Murata Y, et al. Folic acid-responsive neurological diseases in Japan. J Nutr Sci Vitaminol 2001; 47:181-187.

6. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state,” a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.

7. Nilsson K, Gustafson L, Hultberg B. Improvement of cognitive functions after cobalamin/folate supplementation in elderly patients with dementia and elevated plasma homocysteine. Int J Geriatr Psychiatry 2001; 16:609-614.

8. Hunter R. Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet 1970; 1:61-62.

9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed., rev. Washington DC: American Psychiatric Press, 1987.

10.

10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62.

11.

11. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep 1962; 10:799-812.

12.

12. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995.

13.

13. Wechsler D. Wechsler Adult Intelligence Scale-Revised manual. New York: The Psychological Corporation, Harcourt, Brace, and Jovanovich, 1982.

14.

14. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia, Pa: Lea and Febiger, 1983.

15.

15. Benton AL, Hamsher K, Sivan AB. Multilingual aphasia examination. 3rd ed. Iowa City, Ia: AJA Associates, 1994.

16.

16. Wechsler D, Stone CP. Wechsler Memory Scale manual. New York: The Psychological Corporation, Harcourt, Brace and Jovanovich, 1955.

17.

17. Benton AL. Revised Visual Retention Test. 5th ed. New York: The Psychological Corporation, Harcourt, Brace, and Jovanovich, 1955.

18.

18. Reitan RM. Trail Making Test: Manual for administration and scoring. Tucson, Az: Reitan Neuropsychological Laboratory, 1992.

19.

19. Reitan RM, Davidson, LA. Clinical neuropsychology: Current status and applications. New York: Hemisphere, 1974.